SYNTHESIS AND BIOLOGICAL EVALUATION OF PARA-BROMOSPIPERONE AS POTENTIAL NEUROLEPTIC DRUG

被引:18
作者
HUANG, CC
FRIEDMAN, AM
SO, R
SIMONOVIC, M
MELTZER, HY
机构
[1] UNIV CHICAGO,DEPT RADIOL,CHICAGO,IL 60637
[2] UNIV CHICAGO,DEPT PSYCHIAT,CHICAGO,IL 60637
关键词
D O I
10.1002/jps.2600690835
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:984 / 986
页数:3
相关论文
共 6 条
[1]   DEMONSTRATION OF NEUROLEPTIC RECEPTOR-SITES IN MOUSE-BRAIN BY AUTORADIOGRAPHY [J].
HOLLT, V ;
SCHUBERT, P .
BRAIN RESEARCH, 1978, 151 (01) :149-153
[2]   SPECIFIC INVIVO BINDING OF NEUROLEPTIC DRUGS IN RAT-BRAIN [J].
LADURON, P ;
LEYSEN, J .
BIOCHEMICAL PHARMACOLOGY, 1977, 26 (10) :1003-1007
[3]   STUDIES ON MECHANISM OF DOPAMINE-MEDIATED INHIBITION OF PROLACTIN SECRETION [J].
MACLEOD, RM ;
LEHMEYER, JE .
ENDOCRINOLOGY, 1974, 94 (04) :1077-1085
[4]   COMPARISON OF THE EFFECTS OF SUBSTITUTED BENZAMIDES AND STANDARD NEUROLEPTICS ON THE BINDING OF H-3-SPIROPERIDOL IN THE RAT PITUITARY AND STRIATUM WITH INVIVO EFFECTS ON RAT PROLACTIN SECRETION [J].
MELTZER, HY ;
SO, R ;
MILLER, RJ ;
FANG, VS .
LIFE SCIENCES, 1979, 25 (07) :573-583
[5]   CLOZAPINE INCREASES RAT SERUM PROLACTIN LEVELS [J].
MELTZER, HY ;
DANIELS, S ;
FANG, VS .
LIFE SCIENCES, 1975, 17 (03) :339-342
[6]  
SILVERSTEIN RM, 1967, SPECTROMETRIC IDENTI, P73